These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 30471094)

  • 1. Hypoglycaemic effects of glimepiride in sulfonylurea receptor 1 deficient rat.
    Zhou X; Zhang R; Zou Z; Shen X; Xie T; Xu C; Dong J; Liao L
    Br J Pharmacol; 2019 Feb; 176(3):478-490. PubMed ID: 30471094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gliquidone ameliorates hepatic insulin resistance in streptozotocin-induced diabetic Sur1
    Zhang R; Zhou X; Sheng Q; Zhang Q; Xie T; Xu C; Zou Z; Dong J; Liao L
    Eur J Pharmacol; 2021 Sep; 906():174221. PubMed ID: 34081903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extrapancreatic effects of sulfonylureas--a comparison between glimepiride and conventional sulfonylureas.
    Müller G; Satoh Y; Geisen K
    Diabetes Res Clin Pract; 1995 Aug; 28 Suppl():S115-37. PubMed ID: 8529504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the molecular mode of action of the sulfonylurea, glimepiride, at adipocytes.
    Müller G; Geisen K
    Horm Metab Res; 1996 Sep; 28(9):469-87. PubMed ID: 8911985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antidiabetic activity evaluation of glimepiride and Nerium oleander extract on insulin, glucose levels and some liver enzymes activities in experimental diabetic rat model.
    Mwafy SN; Yassin MM
    Pak J Biol Sci; 2011 Nov; 14(21):984-90. PubMed ID: 22514888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of glimepiride on in vivo insulin action in normal and diabetic rats.
    Sato J; Ohsawa I; Oshida Y; Sato Y; Sakamoto N
    Diabetes Res Clin Pract; 1993; 22(1):3-9. PubMed ID: 8137714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of glimepiride (HOE 490) on insulin receptors of skeletal muscles from genetically diabetic KK-Ay mouse.
    Takada Y; Takata Y; Iwanishi M; Imamura T; Sawa T; Morioka H; Ishihara H; Ishiki M; Usui I; Temaru R; Urakaze M; Satoh Y; Inami T; Tsuda S; Kobayashi M
    Eur J Pharmacol; 1996 Jul; 308(2):205-10. PubMed ID: 8840133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The sulfonylurea drug, glimepiride, stimulates glucose transport, glucose transporter translocation, and dephosphorylation in insulin-resistant rat adipocytes in vitro.
    Müller G; Wied S
    Diabetes; 1993 Dec; 42(12):1852-67. PubMed ID: 8243832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacodynamic and pharmacokinetic interaction of losartan with glimepiride-metformin combination in rats and rabbits.
    Nagaraju B; Anilkumar KV
    Indian J Pharmacol; 2021; 53(6):465-470. PubMed ID: 34975134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin potentiates blood glucose lowering effect of glimepiride-pioglitazone combination in streptozotocin-induced diabetic rats.
    Bag S; Das S; Bagchi C; Tripathi SK
    Indian J Pharmacol; 2014; 46(5):562-4. PubMed ID: 25298594
    [No Abstract]   [Full Text] [Related]  

  • 11. Cardiovascular effects of conventional sulfonylureas and glimepiride.
    Geisen K; Végh A; Krause E; Papp JG
    Horm Metab Res; 1996 Sep; 28(9):496-507. PubMed ID: 8911987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fasiglifam/TAK-875, a Selective GPR40 Agonist, Improves Hyperglycemia in Rats Unresponsive to Sulfonylureas and Acts Additively with Sulfonylureas.
    Ito R; Tsujihata Y; Suzuki M; Miyawaki K; Matsuda K; Takeuchi K
    J Pharmacol Exp Ther; 2016 Apr; 357(1):217-27. PubMed ID: 26813930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glimepiride Administered in Chow Reversibly Impairs Glucose Tolerance in Mice.
    Niedowicz DM; Özcan S; Nelson PT
    J Diabetes Res; 2018; 2018():1251345. PubMed ID: 30510962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glimepiride as insulin sensitizer: increased liver and muscle responses to insulin.
    Mori RC; Hirabara SM; Hirata AE; Okamoto MM; Machado UF
    Diabetes Obes Metab; 2008 Jul; 10(7):596-600. PubMed ID: 18355328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct effects of glimepiride on protein expression of cardiac glucose transporters.
    Eckel J
    Horm Metab Res; 1996 Sep; 28(9):508-11. PubMed ID: 8911988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Glimepiride (Amaryl): a review of its pharmacological and clinical profile].
    Bando K; Yamada Y
    Nihon Yakurigaku Zasshi; 2001 Jul; 118(1):59-67. PubMed ID: 11496829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic effects of various antidiabetic and hypolipidaemic agents on a high-fat diet and multiple low-dose streptozocin (MLDS) mouse model of diabetes.
    Arulmozhi DK; Kurian R; Bodhankar SL; Veeranjaneyulu A
    J Pharm Pharmacol; 2008 Sep; 60(9):1167-73. PubMed ID: 18718120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the effects of glimepiride and glibenclamide on adipose tissue tumour necrosis factor-alpha mRNA expression and cellularity.
    Mori Y; Komiya H; Kurokawa N; Tajima N
    Diabetes Obes Metab; 2004 Jan; 6(1):28-34. PubMed ID: 14686960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of glimepiride on pancreatic beta-cell function under hyperglycaemic clamp and hyperinsulinaemic, euglycaemic clamp conditions in non-insulin-dependent diabetes mellitus.
    Clark HE; Matthews DR
    Horm Metab Res; 1996 Sep; 28(9):445-50. PubMed ID: 8911981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glimepiride. A review of its use in the management of type 2 diabetes mellitus.
    Langtry HD; Balfour JA
    Drugs; 1998 Apr; 55(4):563-84. PubMed ID: 9561345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.